Multiple Myeloma

Multiple myeloma, also known as myeloma or plasma cell myeloma, is a "hematological" cancer, meaning it develops in the blood. Multiple myeloma is the second most common cancer of the blood. About 45,000 people have this disease and 14,600 new cases are diagnosed each year in the United States. The peak age of the disease onset is 65 to 70 years of age, but recent statistics indicate that the disease is becoming more prevalent and that people are getting the disease at younger ages.

In multiple myeloma, the body produces too many plasma or myeloma cells. These cells produce antibodies that the body doesn't need, which can form tumors and cause other problems. Although the cause of multiple myeloma is unknown, a number of possible associations between myeloma and a decline in the immune system, genetic factors, certain occupations, exposure to certain chemicals and radiation, and a certain virus have been suggested. Unfortunately, multiple myeloma is fatal. However, new treatments are being developed that are helping patients live longer and healthier lives.

At UCSF Medical Center, blood disorders specialists care for patients with this disease in the Multiple Myeloma Clinic and offer a variety of treatments including chemotherapy, stem cell transplantation, biologic response, vertebralplasty and radiation therapy. In addition, patients are encouraged to participate in clinical trials aimed at improving therapy for all with multiple myeloma.

To make an appointment, please call:
Hematology (415) 353-2421

Reviewed by health care specialists at UCSF Medical Center.
Last updated August 29, 2007